You are here

biosimilars

iBio: Risky, But Early Stage Pipeline Potentially Offers Long-Term Reward

Seeking Alpha

Sat, 02/12/11 - 12:53 pm

Datamonitor: Diabetes growth won't stop CV, metabolic market slide

Fierce Pharma

Thu, 02/10/11 - 10:37 am

cardiovascular disease

Generics Companies Weigh In on Biological Drugs

WSJ

Mon, 01/31/11 - 08:00 am

Biosimilars: Empty Threats?

InVivo

Tue, 01/18/11 - 11:58 am

Biosimilars vitalizing Korea's drug industry

The Korea Times, Korea

Sun, 01/16/11 - 11:44 am

Merck Enlists Parexel to Support Development of Promising Biosimilars

Seeking Alpha

Sun, 01/16/11 - 11:36 am

Merck and Parexel Form Strategic Alliance

Bloomberg

Wed, 01/12/11 - 12:07 pm

Merck BioVentures

Novartis plans trial of equivalent to Roche drug

Marketwatch

Mon, 01/10/11 - 12:16 pm

rheumatoid arthritis

Spectrum Pharma Jumps in With the Big Dogs

Motley Fool

Thu, 01/6/11 - 07:40 am

Spectrum Pharmaceuticals

Regulatory experts see huge challenges on biosimilar rules

Fierce Biotech

Thu, 12/2/10 - 10:20 am

Teva Gets Boost From Biosimilars

Seeking Alpha

Tue, 11/23/10 - 09:37 am

Teva Pharmaceuticals

small molecule drugs

Amgen proposes key hurdles for biosimilar regs

Fierce Biotech

Tue, 11/2/10 - 11:27 am

Lovenox Copycat Takes Market Share From Sanofi

Motley Fool

Sat, 10/23/10 - 10:40 am

Biosimilar threat tarnishes Novo's star status

Reuters

Tue, 10/19/10 - 11:07 am

Biocon Surges on $200 Million Payment From Pfizer for Biosimilar Insulin

Bloomberg

Tue, 10/19/10 - 09:17 am

EMA: Few pharmas expected to tackle biosimilar antibodies

Fierce Biotech

Mon, 10/4/10 - 07:51 pm

Good News for Hospira

Yahoo/Zacks.com

Mon, 09/27/10 - 12:01 pm

Biosimilars: This Decade's Most Disruptive Technology

PharmExec

Thu, 09/23/10 - 09:40 am

FDA Schedules Meeting on Biosimilars

TheStreet.com

Mon, 09/20/10 - 12:20 pm

MedImmune Bets Its Fate on “Biobetters”

PharmExec

Fri, 09/10/10 - 11:21 am

Pages